Newly Released Data Stirs Naproxen Debate
Washington Post - Nov 17, 2006
By Steven Reinberg. FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting ...
|
|
The New England Journal missed Vioxx warning signs
Pittsburgh Post-Gazette - Pittsburgh Post Gazette - May 15, 2006
23, 2000, and the occasion was celebrated by Merck in a press release. Merck submitted data from the Vigor study to the FDA because it wanted to add the ...
|
|
|
New Vioxx Revelations
Forbes - Feb 22, 2006
The New England Journal of Medicine released internal Merck memos indicating that ... While this data was not available when the manuscript was submitted, ...
|
|
Some patients back on Celebrex
USA Today - Aug 31, 2006
The biggest study, at $100 million, will compare Celebrex with naproxen and ibuprofen. ... He expects the study's full results to be released by year's end. ...
|
|
Jury Absolves Merck in NJ Trial
1010 Wins - Jul 13, 2006
Data released since then indicate the heart risks started much sooner and ... as users of the older painkiller naproxen, sold under the brand name Aleve. ...
|
|
|
Merck's Drug Data Sowing Conflict
TheStreet.com - TheStreet.com (subscription) - Nov 24, 2006
... or NSAID, the same class that includes naproxen and ibuprofen. ... began several months before Merck released the results of the study known as MEDAL. ...
|
|
|
NEJM sat on Vioxx article warnings for years: WSJ
Medical Marketing & Media - Medical Marketing and Media - May 15, 2006
... the NEJM article's theory that naproxen had a protective effect on the heart. ... In related news, data released last week by Merck show that Vioxx ...
|
|
